Navigation Links
Photo: New Data Show Gleevec(R) Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment
Date:12/9/2007

- Risk of disease progression continues to drop from the second year of treatment; no patients taking Gleevec in sixth year progressed from initial

disease phase - Long-term survival trend may suggest many patients could approach normal

life expectancy with continued treatment

EAST HANOVER, N.J., Dec. 9 /PRNewswire-FirstCall/ -- New data from the largest clinical trial in newly diagnosed patients with a life-threatening form of leukemia showed that long-term use of Gleevec(R) (imatinib mesylate) tablets(1) can halt progression to advanced disease stages in the sixth year of treatment.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/novartis/31035/

Results of the International Randomized Interferon versus STI571 (IRIS) study reveal that after two years of treatment the rate of disease progression continued to decline and fell to 0% in the study's sixth year. In addition, the estimated overall six-year survival rate for patients treated with Gleevec was 88%.

Lead investigators presented the latest findings from this landmark study involving more than 1,100 newly diagnosed patients with a form of the disease known as Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) at the 49th Annual Meeting of the American Society of Hematology (ASH).

Patients in the initial (chronic) phase of CML who received continuous treatment with Gleevec did not progress to advanced stages of the disease. Without treatment, CML typically progresses over three to five years from the initial phase through a transition (accelerated) phase to a rapidly fatal form called blast crisis(1).

"If this survival trend continues, many patients with CML may approach normal life expectancy with continued Gleevec treatment," said Brian Druker, MD, director of the Oregon Health & Scienc
'/>"/>

SOURCE Novartis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer
2. Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
3. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
4. Video and Photo: U.S. Department of Health & Human Services and Ad Council Join NFL to Combat Childhood Obesity
5. Photo: Introducing a New Line of Baby and Toddler Shirts that Can Help Protect Innocent Babies During Flu Season
6. Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
7. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
8. Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders
9. Brain Lesions Predict MS Progression
10. Pregnancy may slow -- not accelerate -- progression to AIDS
11. Progression of SIV infection in monkeys raises
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Westbury, New York (PRWEB) November 24, 2014 ... recently contacted by the Family and Children's Association ... products such as soap, shampoo, mouthwash and other such ... senior citizens who are home bound, living in nursing ... are intended to greatly enhance the well being of ...
(Date:11/24/2014)... 24, 2014 ReAdmission Solutions, LLC ... management services to health plans, hospitals, and accountable ... Management software suite. ReAdmission Solutions will use ... program to reduce patients' avoidable readmissions to hospitals. ... Care Management, Utilization Management, and Appeals & Grievances. ...
(Date:11/23/2014)... 2014 iFitDress.com, a well-known wedding dress manufacturer, ... gowns . They are now offered at deeply discounted ... last from now to Dec. 15. The main purpose of ... the company’s high quality items are ideal options for ladies ... sum of money. All its new mint cocktail dresses are ...
(Date:11/23/2014)... NY (PRWEB) November 23, 2014 ... allege heart attacks, strokes, deep vein thrombosis and ... in a federal multidistrict litigation (MDL) underway in ... reports. , Court documents updated on November ... Litigation (JPML) show the filing of 259 lawsuits ...
(Date:11/23/2014)... To show thanks to new and old customers, ... white evening dresses for weddings. Customers who need custom ... is a distinguished dress manufacturer, and it is among the ... for a very long time. The CEO of this company ... be able to buy not only a beautiful dress, but ...
Breaking Medicine News(10 mins):Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2
... FREMONT, Calif., June 2 Allscripts (Nasdaq: ... connectivity solutions for physicians and hospitals, and SYNNEX Corporation ... services company, today announced that SYNNEX, through its SYNNEX ... Health Record (EHR) to Allscripts authorized resellers who are ...
... Remember CPR Instructions , , CHANDLER, Ariz., June 2 Years ... you knew what to do if someone was having a heart attack, ... How often? And time is of the essence. Do you really have ... Now a small business has come forward with a simple way to ...
... One stool sample can be used to perform several screens, ... testing of a person,s stool can accurately screen for more ... found. , While DNA stool testing has been successfully ... Mayo Clinic have found that the noninvasive screening is also ...
... Philadelphia, 2 June 2009 A closer look at ... thoracic transplantation is required, according to an educational advisory ... (ISHLT) in the July 2009 issue of The ... ), published by Elsevier. ...
... Tasty Way to do More for Your Heart , ... premier natural food company, today announced the addition of whole ... of foods. The new whole wheat crackers are as delicious ... and antioxidants, making them the first nationally distributed crackers to ...
... Two studies from AstraZeneca (NYSE: AZN ... treated with NEXIUM(R) (esomeprazole magnesium) 20 mg daily experienced ... compared with patients taking placebo over four weeks(1). NEXIUM ... and other symptoms associated with GERD. NEXIUM, in ...
Cached Medicine News:Health News:Allscripts and SYNNEX Corporation Form Distribution Partnership to Accelerate Adoption of Electronic Health Records 2Health News:Allscripts and SYNNEX Corporation Form Distribution Partnership to Accelerate Adoption of Electronic Health Records 3Health News:Allscripts and SYNNEX Corporation Form Distribution Partnership to Accelerate Adoption of Electronic Health Records 4Health News:Allscripts and SYNNEX Corporation Form Distribution Partnership to Accelerate Adoption of Electronic Health Records 5Health News:Convenient Safety Magnets Tell You What To Do In An Emergency 2Health News:Simple Test Could Detect More Gastrointestinal Cancers 2Health News:More stringent evaluation on the use of generic medications in thoracic transplantation 2Health News:Kashi Company Debuts Heart to Heart(TM) Whole Grain Crackers 2Health News:Kashi Company Debuts Heart to Heart(TM) Whole Grain Crackers 3Health News:AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances 2Health News:AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances 3Health News:AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances 4Health News:AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances 5
(Date:11/22/2014)... 21, 2014 Research and Markets  has announced ... Industry Report, 2014-2017" report to their offering. ... Chinese recombinant protein drug market has been expanding rapidly ... and the like. During 2005-2013, sales of recombinant protein ... CAGR of 19.1%, and it is projected that ...
(Date:11/21/2014)...  Alere Inc. (NYSE: ALR ), a ... Juliet Cunningham as Vice President, Investor Relations. In ... driving communications with the investment community. "As ... to increase shareholder value, it is critical that we ... Chief Executive Officer. "We are delighted that Juliet ...
(Date:11/21/2014)... CORONA, Calif. and VIENNA, Va. ... an innovative in-home care provider that operates in ... with BeClose, a leading provider of remote caregiving technology. Alta ... new and existing client receiving homecare services. ... believe this technology is the key to providing the ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alere Appoints Juliet Cunningham to Lead Investor Relations 2Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2
... Paratek Pharmaceuticals, Inc. today,announced positive Phase 2 ... first-in-class aminomethylcycline (AMC). The Phase 2 study compared,safety ... of PTK 0796 to,Zyvox(R) in the treatment of ... Paratek,s trial met its primary safety and,tolerability endpoint, ...
... United Kingdom, Oct. 24 Minster,Pharmaceuticals plc (AIM: ... psychiatric disorders, is pleased to announce positive,results from ... in the prevention,of migraine with aura. The median ... in patients receiving tonabersat when compared with placebo. ...
Cached Medicine Technology:Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 3Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 4Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura 2Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura 3
10 L, Bulk Recommended for 2, 5 and 10 L pipettes....
This extended 10 L tip additionally combats contamination by keeping your pipettor out of 1.5 L and 2.0 L tubes....
... tips. Each box contains 1000 tips (5 bags ... tips (4 bags of 50 tips). Also available ... per pack. Bulk Packs are sealed with a ... quick access to Gilsons Diamond Tips. Bulk Packs ...
1000 L, Bulk, blue Recommended for 500 and 1000 L pipettes....
Medicine Products: